Conference abstractPublished 28 Jun 2022

The Recent progress on cheminformatics approaches to epigenetic drug discovery

Authors: Zoe Sessions

Journal of Psychology and Brain Studies

Volume 6 · Issue 6 · Pages 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The ability of epigenetic markers to affect genome function has enabled transformative changes in drug discovery, especially in cancer and other emerging therapeutic areas. Concordant with the introduction of the term ‘epi-informatics’, the size of the epigenetically relevant chemical space has grown substantially and so did the number of applications of cheminformatic methods to epigenetics. Recent progress in epi-informatics has improved our understanding of the structure–epigenetic activity relationships and boosted the development of models predicting novel epigenetic agents. Herein, we review the advances in computational approaches to drug discovery of small molecules with epigenetic modulation profiles, summarize the current chemogenomics data available for epigenetic targets, and provide a perspective on the greater utility of biomedical knowledge mining as a means to advance the epigenetic drug discovery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Psychology and Brain Studies.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Psychology and Brain Studies
  • SubjectMental Health and Psychology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Zoe Sessions”